J Frontier Co (FRA:R0L) EBIT: €2.5 Mil (TTM As of Nov. 2025)


FRA:R0L J Frontier Co Ltd FRA:R0L
41 GF Score
Price €8.10
GF Value €32.28
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is J Frontier Co EBIT?

J Frontier Co FRA:R0L 41 EBIT is €2.5 Mil as of Nov. 2025. GuruFocus rates FRA:R0L with a GF Score™ of 41/100 and a GF Value™ of €32.28 (Significantly Undervalued). The stock has 7 warning signs investors should review.

J Frontier Co's earnings before interest and taxes (EBIT) for the three months ended in Nov. 2025 was €-0.8 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Nov. 2025 was €2.5 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. J Frontier Co's annualized ROC % for the quarter that ended in Nov. 2025 was -6.93%. J Frontier Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Nov. 2025 was -50.48%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. J Frontier Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Nov. 2025 was 3.77%.


J Frontier Co  (FRA:R0L) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

J Frontier Co's annualized ROC % for the quarter that ended in Nov. 2025 is calculated as:

ROC % (Q: Nov. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Aug. 2025 ) + Invested Capital (Q: Nov. 2025 ))/ count )
=-2.8 * ( 1 - 6.92% )/( (35.386 + 39.848)/ 2 )
=-2.60624/37.617
=-6.93 %

where

Note: The Operating Income data used here is four times the quarterly (Nov. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

J Frontier Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Nov. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Nov. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Aug. 2025  Q: Nov. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-3.364/( ( (0.979 + max(6.288, 0)) + (0.858 + max(5.204, 0)) )/ 2 )
=-3.364/( ( 7.267 + 6.062 )/ 2 )
=-3.364/6.6645
=-50.48 %

where Working Capital is:

Working Capital(Q: Aug. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(7.265 + 10.73 + 2.183) - (12.183 + 0 + 1.707)
=6.288

Working Capital(Q: Nov. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(7.563 + 10.383 + 1.701) - (12.772 + 0 + 1.671)
=5.204

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Nov. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

J Frontier Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Nov. 2025 )
=2.474/65.554
=3.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


J Frontier Co EBIT Related Terms


J Frontier Co EBIT Historical Data

* Premium members only.

The historical data trend for J Frontier Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

J Frontier Co EBIT Chart

J Frontier Co Annual Data
Trend May19 May20 May21 May22 May23 May24 May25
EBIT
Get a 7-Day Free Trial 5.13 5.15 -12.32 -10.00 1.88

J Frontier Co Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.23 0.46 0.08 -0.84 2.78

J Frontier Co EBIT Competitor Comparison

For the Pharmaceutical Retailers subindustry, J Frontier Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


J Frontier Co EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, J Frontier Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where J Frontier Co's EV-to-EBIT falls into.


FRA:R0L
41GF Score
J Frontier Co Ltd FRA:R0L
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

J Frontier Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €2.5 Mil mean?
J Frontier Co (FRA:R0L) has a EBIT of €2.5 Mil as of Nov. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on J Frontier Co.
Is J Frontier Co's EBIT too high?
J Frontier Co's current EBIT is €2.5 Mil. Overall, J Frontier Co has a GF Score™ of 41/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does J Frontier Co's EBIT compare to competitors?
J Frontier Co's EBIT of €2.5 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on J Frontier Co. J Frontier Co's current EBIT is €2.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is J Frontier Co stock overvalued right now?
Based on GuruFocus' analysis, J Frontier Co (FRA:R0L) is currently considered Significantly Undervalued. The stock's GF Value™ is €32.28, compared to a current price of €8.10 — trading 74.9% below its estimated fair value. The current EBIT is €2.5 Mil. J Frontier Co's overall GF Score™ is 41/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For J Frontier Co (FRA:R0L), the current EBIT is €2.5 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is J Frontier Co (FRA:R0L) Overvalued in 2026?

Based on GuruFocus' analysis, J Frontier Co stock appears to be undervalued. The current stock price of €8.10 is trading 74.9% below its estimated GF Value™ of €32.28. GuruFocus considers J Frontier Co to be Significantly Undervalued.

Key valuation signals for FRA:R0L:

  • EBIT: €2.5 Mil
  • GF Value™: €32.28 vs. price of €8.10 (74.9% below fair value)
  • GF Score™: 41/100 with 7 warning signs

No single metric tells the full story. See the FRA:R0L stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


J Frontier Co Business Description

Other Exchanges 2934:Japan
Address 2-9-9 Shibuya, SANWA Aoyama Building, 8th floor, Shibuya-ku, Tokyo, JPN, 150-0002
J Frontier Co Ltd is engaged in the healthcare sales business, medical care sales business and healthcare marketing business.
41GF Score

Get the complete analysis for FRA:R0L

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.10
Price
€32.28
GF Value